GBA1 and Parkinson disease: One of the more unexpected associations between sphingolipids and disease discovered in the past 15 years or so is the genetic connection between mutations in the GBA gene, the gene that encodes acid-beta-glucosidase, the lysosomal enzyme that cleaves the simple glycosphingolipid, glucosylceramide, and Parkinson’s disease [11].